indicated that thirty percent of mice with choline-deficient high-fat diet developed HCC with similar genetic alterations of human NAFLD-HCC, but anti-PD-1 therapy failed to regress tumor burden in spite of increased infiltration of immune effector cells, and this effect could be attributed to impaired function of CD8+ and NK cells (121). Here, PDCD1 is linked to hepatocellular carcinoma.